Vivos (RDGL) Change in Account Payables (2010 - 2019)
Vivos (RDGL) reported Change in Account Payables of -$21600.0 for Q4 2019, up 81.73% on a YoY basis from -$11885.8 in Q4 2018, and down 264.57% sequentially from $13125.0 in Q3 2019.
Vivos (RDGL) Change in Account Payables (2010 - 2019) Analysis & Trends
Vivos (RDGL) has 10 years of Change in Account Payables data on file, last reported at -$21600.0 in Q4 2019.
- For the quarter ending Q4 2019, Change in Account Payables rose 81.73% year-over-year to -$21600.0; the trailing twelve-month figure through Dec 2019 stood at -$6500.0 (up 94.93% YoY), and the FY2019 full-year result was -$6500.0, up 94.93% from the prior year.
- Change in Account Payables fell to -$21600.0 in Q4 2019, from $13125.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $329766.0 in Q3 2016 to a low of -$170241.0 in Q1 2016.
- A 5-year average of $3550.6 and a median of $3329.0 in 2018 frame the typical range for Change in Account Payables.
- Peak annual rise in Change in Account Payables reached 568.87% in 2016, while the deepest fall reached 528.22% in 2016.
- Tracing RDGL's Change in Account Payables over 5 years: stood at $103499.0 in 2015, then plunged by 36.24% to $65990.0 in 2016, then slumped by 172.35% to -$47746.0 in 2017, then tumbled by 147.61% to -$118223.0 in 2018, then surged by 81.73% to -$21600.0 in 2019.
- Business Quant data shows RDGL's Change in Account Payables at -$21600.0 in Q4 2019, $13125.0 in Q3 2019, and -$1525.0 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.03 Bn | 175.74 Bn | 6.27 Bn | - |
| 2 | Stryker | 129.38 Bn | 126.50 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 108.86 Bn | 99.64 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 47.66 Bn | 43.99 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.64 Bn | 27.52 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn | 221.00 Mn |
| 8 | Smith & Nephew | 27.02 Bn | 26.44 Bn | - | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn | - |
| 10 | Vivos | 27.57 Mn | 26.01 Mn | -3,105.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -21,600.00 |
| Dec 31, 2019 | -21,600.00 |
| Sep 30, 2019 | 13,125.00 |
| Sep 30, 2019 | 13,125.00 |
| Jun 30, 2019 | -1,525.00 |
| Jun 30, 2019 | -1,525.00 |
| Mar 31, 2019 | 3,500.00 |
| Mar 31, 2019 | 3,500.00 |
| Dec 31, 2018 | -118,223.00 |
| Dec 31, 2018 | -118,223.00 |
| Sep 30, 2018 | 3,329.00 |
| Sep 30, 2018 | 3,329.00 |
| Jun 30, 2018 | 4,025.00 |
| Jun 30, 2018 | 4,025.00 |
| Mar 31, 2018 | -17,309.00 |
| Mar 31, 2018 | -17,309.00 |
| Dec 31, 2017 | -47,746.00 |
| Dec 31, 2017 | -47,746.00 |
| Sep 30, 2017 | -44,624.00 |
| Sep 30, 2017 | -44,624.00 |